COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 481: Articles 4801-4810  | Next

SARS-CoV-2 introductions to the island of Ireland
Rice, A. M., Troendle, E. P., Bridgett, S., Firoozi Nejad, B., McKinley, J. M., The COVID-19 Genomics UK consortium, , National SARS-CoV-2 Surveillance & Whole Genome Sequencing (WGS) Programme, , Bradley, D. T., Fairley, D., Bamford, C. G. G., Skvortsov, T., Simpson, D. A.
10.1101/2023.05.11.23289783 — Posted: 2023-05-11
COVID-19 in meat plants: activation of a Target Prevention Plan, in Italy
Di Leone, G., Bertinato, L., Brambilla, G., Manno, V., Napolano, F., Savi, S., Settimo, G., Lagravinese, D.
10.1101/2023.05.08.23289661 — Posted: 2023-05-11
Factors associated with the near miss of pregnant and postpartum women hospitalized by Covid-19
Schultz da Silva, A. C., Moroskoski, M., de Oliveira, N. N., de Brito, F. A. M., Silva, M. d. A. P., Salci, M. A., Carreira, L., Vissoci, J., de Oliveira, R. R.
10.1101/2023.05.10.23289809 — Posted: 2023-05-11
D614G and Omicron SARS-CoV-2 variant spike proteins differ in the effects of N-glycan modifications on spike expression, virus infectivity, and neutralization by some therapeutic antibodies
Lusvarghi, S., Stauft, C. B., Vassell, R., Williams, B., Baha, H., Wang, W., Neerukonda, S. N., Wang, T., Weiss, C. D.
10.1101/2023.05.10.540228 — Posted: 2023-05-11
Metabolic alterations unravel the materno fetal immune responses with disease severity in pregnant women infected with SARS-CoV-2
Hora, S., Pahwa, P., Siddqui, H., Saxena, A., Kashyap, M., Sevak, J. K., Singh, R., Javed, M., Yadav, P., Kale, P., Ramakrishna, G., Rathore, A., Maras, J. S., Tyagi, S., Sarin, S. K., Trehanpati, N.
10.1101/2023.05.10.540101 — Posted: 2023-05-11
Mild/Asymptomatic Maternal SARS-CoV-2 Infection Leads to Immune Paralysis in Fetal Circulation and Immune Dysregulation in Fetal-Placental Tissues
Doratt, B. M., Sureshchandra, S., True, H., Rincon, M., Marshall, N. E., Messaoudi, I.
10.1101/2023.05.10.540233 — Posted: 2023-05-11
The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs
Frediani, J., Parsons, R., McLendon, K. B., Westbrook, A., Lam, W. A., Martin, G., Pollock, N. R.
10.1101/2023.05.09.23289735 — Posted: 2023-05-10
Preparing correctional settings for the next pandemic: a modelling study of COVID-19 outbreaks in two high-income countries
Kwon, J. A., Bretana, N. A., Kronfli, N., Dussault, C., Grant, L., Galouzis, J., Hoey, W., Blogg, J., Lloyd, A. R., Gray, R. T.
10.1101/2023.05.08.23289690 — Posted: 2023-05-10
Tracking the prevalence and emergence of SARS CoV2 variants of concern using a regional genomic surveillance program
Jung, A., Droit, L., Febles, B., Fronick, C., Cook, L., Handley, S. A., Parikh, B. A., Wang, D.
10.1101/2023.05.08.23289687 — Posted: 2023-05-10
Severity of SARS-CoV-2 Omicron XBB subvariants in Singapore
Pung, R., Kong, X. P., Lin, C., Chae, S.-R., Chen, M. I.-C., Lee, V., Ho, Z. J. M.
10.1101/2023.05.04.23289510 — Posted: 2023-05-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).